ISU Abxis Co., Ltd.   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Bundang-gu Korea, Republic of (2001)

Organization Overview

First Clinical Trial
2010
NCT01881633
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

ISU Abxis Co., Ltd.